Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 25;12(1):45.
doi: 10.1186/s13613-022-01020-w.

Noninferiority trials: a specific design with a particular methodology

Martin Ruste  1   2 , Jean-Luc Fellahi  3   4   5 , Matthias Jacquet-Lagrèze  3   4   5
Affiliations

Noninferiority trials: a specific design with a particular methodology

Martin Ruste et al. Ann Intensive Care. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Martin Ruste, Jean-Luc Fellahi and Matthias Jacquet-Lagrèze have no conflict of interest related to this letter.

Figures

Fig. 1
Fig. 1
Graphical representation in noninferiority trial if efficacy is measured by failure rates (lower is better). Delta: margin of noninferiority
See this image and copyright information in PMC

Comment on

References

    1. Franco RA, de Almeida JP, Landoni G, Scheeren TWL, Galas FRBG, Fukushima JT, et al. Dobutamine-sparing versus dobutamine-to-all strategy in cardiac surgery: a randomized noninferiority trial. Ann Intensive Care. 2021;11(1):15. doi: 10.1186/s13613-021-00808-6. - DOI - PMC - PubMed
    1. Mauri L, D’Agostino RB. Challenges in the design and interpretation of noninferiority trials. N Engl J Med. 2017;377(14):1357–1367. doi: 10.1056/NEJMra1510063. - DOI - PubMed
    1. Schumi J, Wittes JT. Through the looking glass: understanding non-inferiority. Trials. 2011;3(12):106. doi: 10.1186/1745-6215-12-106. - DOI - PMC - PubMed
    1. Piaggio G, Elbourne DR, Pocock SJ, Evans SJW, Altman DG, CONSORT Group Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594–2604. doi: 10.1001/jama.2012.87802. - DOI - PubMed
    1. Le Henanff A, Giraudeau B, Baron G, Ravaud P. Quality of reporting of noninferiority and equivalence randomized trials. JAMA. 2006;295(10):1147–1151. doi: 10.1001/jama.295.10.1147. - DOI - PubMed